Beijing Complement Therapeutics Co., Ltd. China is a National High-Tech Enterprise and a high-tech biomedical company dedicated to the R&D and application of targeted complement innovative drugs. The company has pioneered the world's first R&D platform for complement inhibitors that enables precise, dynamic targeting of complement activation sites. It currently holds 11 invention patents. Our targeted complement innovative drugs are globally competitive in both their design philosophy and target selection.

The company's founding scientific team comprises top complement experts from both China and the United States. With eight pipeline products currently under development, the first new drug is expected to be launched between 2028 and 2029.

Looking ahead, Beijing Complement Therapeutics aspires to become a truly world-leading enterprise in China — a premier global player in the field of targeted complement drug development — and to make even greater contributions to society.

Biopharmaceuticals and Advanced Therapies

EuroEyes Presbyond LBV Laser Vision Correction permanently resolves myopia and presbyopia. Developed by Prof. Dan Reinstein, EuroEyes’ Medical Director of the International Medical Advisory Board, this innovative technique is backed by his extensive clinical experience with over 10,000 successful cases. Prof. Reinstein has also undergone the LBV procedure himself, validating its safety and efficacy. It optimizes binocular vision for clear distance, intermediate, and near sight without intraocular surgery, offering a life-changing solution for adults aged 38+.    

Biopharmaceuticals and Advanced Therapies

Yaohai Bio-Pharma specializes in CRDMO services for microbial expression systems, focusing on recombinant proteins/peptides, mRNA therapeutics, and nanobodies. The company offers one-stop new drug R&D services from engineered strain construction and process development to GMP manufacturing and regulatory submissions. Having supported over 300 projects and collaborated with more than 200 clients, Yaohai leverages its full-chain technical platform and rigorous quality management system to help global partners accelerate clinical trials and bring new drugs to market efficiently.

Biopharmaceuticals and Advanced Therapies

This project targets hepatocellular carcinoma (HCC) by constructing a novel antigen mRNA-LNP targeting professional antigen-presenting cells (pAPCs) such as dendritic cells (DCs) and macrophages. This system efficiently activates T cells through a dual MHC I/II pathway. Unlike traditional mRNA-LNP vaccines, which primarily target humoral immunity, this system significantly enhances tumor-specific T-cell immunity, providing a novel approach for HCC immunotherapy.    

Biopharmaceuticals and Advanced Therapies

Neuregen Therapeutics leverages its leading innovative platform technology—in situ transdifferentiation—to develop novel gene therapy drugs, with a pipeline focused on neurological diseases and oncology. Its lead glioma program has obtained IND clearances in both China and the United States, marking the world’s first formal clinical project in this technological field. The company has completed four rounds of financing from renowned investment institutions to date.    

Biopharmaceuticals and Advanced Therapies

The novel "β-polymeric antimicrobial peptide": enzyme & 300°C resistant, salt-enhanced. 0-toxicity. Global antimicrobial solutions for medical, textile & aquaculture.

Biopharmaceuticals and Advanced Therapies

BORNS TORSS® Oral Surgery Robot, through intelligent control of high-sensitivity robotic arms and precision surgical instruments, passes through complex physiological bends in the throat and performs precise minimally invasive operations on tissues in extremely narrow spaces, including tumors in hard to reach areas such as the mouth, throat, and lower throat. It breaks through the difficulties and pain points of traditional surgery and creates a new minimally invasive robotic surgical treatment method.    

Medical Devices and Diagnostics

YuniBio develops world-first UHMWPE nanomembrane for scar-free wound healing. Highly breathable, bacteria-proof, waterproof. Solves scarring and slow healing.    

Medical Devices and Diagnostics

COC/COP Pre-Filled-Syringe (Luer-Lock) assembly line 
HAHN Automation is one of the leading suppliers for the assembly of COC/COP pre-filled syringes (PFS) with Luer-Lock connector. Leading supplier for fully automatic Luer-Lock assembly lines as per US FDA and EU GMP requirements. Proven track-record of HAHN-Syringe lines successfully running in the market.
·  Special “minimal touch” COC/COP barrel take-out and handling.
·  In-house developed and FDA proven siliconization technology.
·  Supertrak Transport System for full process flexibility, to minimize particles and maximize overall OEE.
·  Designed for PFS range 0.5ml-10ml
·  Scalable output concept for 8/16/32 cavities mold
·  From IMM to sealed Nest & Tub packaging, laser marking and unloading      

Medical Devices and Diagnostics

Idneo MedTech: end-to-end engineering & manufacturing partner for regulated diagnostics & monitoring devices. ISO 13485 certified. EU, US & Asia delivery    

Medical Devices and Diagnostics

This project develops an innovative solution for repairing oral and maxillofacial, alveolar, spinal, limb and cranial bone defects. It addresses the clinical limitations of conventional PMMA biomaterials, including poor osseointegration caused by bio-inertness, tissue thermal injury from polymerization heat, and cytotoxic residual monomers that hinder tissue regeneration. Adopting low-temperature radical polymerization technology, we developed a porous PMMA composite bone adhesive with degradable microspheres. It features low curing heat, minimal residual monomers and high biocompatibility, with bioactivity and controllable degradation to facilitate bone regeneration. Beyond stomatology and orthopedics, it has been applied to optic nerve repair prosthesis packaging and selected for China’s Innovation Task Bidding & Leading Program for Biomedical Materials (2nd Batch).    

Medical Devices and Diagnostics

To address the challenges of traditional packaging for invisible orthodontic aligners, MULTIVAC has developed the industry's first fully automated line centered on a thermoforming packaging machine. The line integrates automatic sorting, loading, packaging, and labeling, enabling rapid changeover across multiple product specifications and full end-to-end traceability. This solution improves packaging efficiency by 8 to 10 times. The line is estimated to produce over 10 million packs annually.    

Medical Devices and Diagnostics

FolliCT-Precision Laser Guidance for Image-Based Interventions
· FolliCT Laser Needle Guidance for Interventional Radiology Uses a laser light to guide any straight needle. Based on a CT or Cone Beam CT image, the laser is set to highlight the intended needle path to the target inside the patient. Simply advance the needle by keeping the light on the needle hub.
· Focus on the Patient and Intervention.
· Fast Integration and Easy Installation. FolliCT can be integrated with any interventional CT or Cone Beam CT unit. It works with all types of interventional straight needles.
· Saves Time and Decreases Radiation with FolliCT, less control scans and needle corrections are necessary, which reduces the treatment time.     

Medical Devices and Diagnostics

Raflon: modified PTFE with 10,000x wear resistance, zero cold flow, 0% porosity. Enables durable seals, H2 membranes, 5G dielectrics, medical implants.    

Medical Devices and Diagnostics

Orange Factor is pioneering China's first IHC data-level infrastructure platform. By defining IHC as the pivotal hub for protein validation in biomanufacturing, we control the standardization entry through proprietary high-throughput automated systems.Each installation acts as a digital data node. This enables a "Value Flywheel" connecting drug R&D, Companion Diagnostics (CDx), and AI-assisted pathology, driving an industrial paradigm shift in precision oncology.    

Medical Devices and Diagnostics

Disposable Sterile Medical Laser probe (Blast Shield) can be matched with current medical laser devices in the domestic market. Through the specially designed high-power F-SMA905 blast shield connector, it can meet clinical demands for increasing output power, while significantly reducing the risk of probe damage and improving surgical efficiency. This product is mainly widely used in fields such as urinary stone removal, epilepsy treatment, and tumor treatment.    

Medical Devices and Diagnostics

Non-Invasive Surgery 3.0 – Intelligent Dual-Energy Robotic Platform
Diana9, the world’s first dual-energy robotic HIFU system, uniquely enables sub-millisecond switching between histotripsy and thermal ablation. Powered by phased-array electronic steering and a modular robotic platform, it redefines precision in non-invasive therapy—leading the way into Intelligent Surgery 3.0.    

Medical Devices and Diagnostics

We are a high-tech enterprise focused on closed-loop brain-computer interface (BCI) intervention technologies, dedicated to reshaping clinical diagnosis, treatment, and rehabilitation in the field of mental health through a dual-engine model combining Hardware-as-a-Service (HaaS) and Data-as-a-Service (DaaS).    

Healthy Aging and Preventive Health

Rooted in ancient wisdom, Medicine-Food Homology drives a trillion-yuan market. We work with top hospitals using bioactives to balance homeostasis and offer high-bioavailability preventive nutrition.    

Healthy Aging and Preventive Health

Bayer Foundation funds XinBo Company (NewLife & Buurtzorg) to create "I Care you," a community home care model in Nanning. The one-year project serves 240 disabled seniors, cutting costs 30%-40% vs. institutional care and raising health scores by 20%+. Through reduced expenses and talent development, it builds a replicable "Nanning Model" for inclusive elderly care, delivering sustainable social value.    

Healthy Aging and Preventive Health

Shanghai Feipu Intelligent Technology Co., Ltd., founded in 2021, is the world's first foundational large language model company in the field of computational biogenomics. The company has developed a systemic biological operating system. By leveraging highly efficient algorithmic architecture and advanced compression capabilities, Feipu enables cost-effective and rapid deployment of its solutions. The company's platform spans from genotype to phenotype, offering genetic prediction, early detection of health and disease risks, precision intervention, targeted medication guidance, and precision diagnostics. The technical team, with over 20 years of research experience in computational biogenomics, hails from world-renowned institutions such as the Max Planck Institute, the Chinese Academy of Sciences, and Yale University. Feipu's research has achieved multiple world-class breakthroughs and has been featured in interviews by Nature and Science magazine. Its breakthrough application, the VitaMirror non-invasive health screening robot, has been deployed at scale in various health and medical scenarios both in China and internationally.    

Healthy Aging and Preventive Health

Qijia Series is an intelligent care robot for the elderly. It features a one-click switch between operation and wheelchair modes, assisting with daily tasks such as fetching water, feeding, and mobility—a 24/7 robotic caregiver .    

Healthy Aging and Preventive Health

Established in 2007, BMP is a Sino-German construction group with Grade A design and Grade II EPC qualifications. It specializes in pharmaceutical plants, high-grade cleanrooms, laboratories, industrial and public buildings. Offering full-cycle design, consulting and integrated project solutions, we focus on regulatory compliance, energy efficiency, sustainability and cost-effective investment.    

Other [Engineering/Construction & ESG Innovative Service for Biopharmaceutical Industry]

Modern laboratories face rising operational challenges. They are highly energy intensive due to rigid HVAC systems and limited transparency, leading to high operating costs and increasing ESG pressure. At the same time, laboratory space is expensive but often poorly utilized because decisions are rarely based on real usage data.
Labor operators also struggle with staff shortages. Fewer people must manage more systems, while manual processes and fragmented tools increase workload and safety risks, especially for lone workers. In addition, many labs rely on disconnected systems such as BMS, access control, and asset management, resulting in limited transparency and reactive operations.
Finally, traditional laboratories are often not prepared for automation, robotics, or AI. A Smart Lab addresses these issues by digitally integrating buildings, lab operations, and users to create efficient, safe, and future ready laboratory environments.    

Other [Digitalization of laboratory buildings]

WIJ, founded in August 2023, is an innovative enterprise with a core team composed of distinguished experts from world-renowned universities and institutions, including Harvard University, UTS, and CAS. The company specializes in the research, production and sales of polypeptide-based and plant-derived active ingredients applied in the cosmetics, food and pharmaceutical industries.    

Other [Food and Healthcare Industry]